Growth Metrics

Tandem Diabetes Care (TNDM) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$21.1 million.

  • Tandem Diabetes Care's Income towards Parent Company rose 906.63% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$203.4 million, marking a year-over-year decrease of 6039.75%. This contributed to the annual value of -$96.0 million for FY2024, which is 5686.42% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Income towards Parent Company stood at -$21.1 million, which was up 906.63% from -$52.4 million recorded in Q2 2025.
  • Tandem Diabetes Care's Income towards Parent Company's 5-year high stood at $10.8 million during Q4 2021, with a 5-year trough of -$130.6 million in Q1 2025.
  • For the 5-year period, Tandem Diabetes Care's Income towards Parent Company averaged around -$31.7 million, with its median value being -$23.3 million (2024).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first surged by 16089.63% in 2021, then crashed by 95194.85% in 2022.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Income towards Parent Company stood at $10.8 million in 2021, then plummeted by 247.28% to -$15.9 million in 2022, then crashed by 89.03% to -$30.0 million in 2023, then soared by 102.59% to $775000.0 in 2024, then tumbled by 2828.13% to -$21.1 million in 2025.
  • Its Income towards Parent Company was -$21.1 million in Q3 2025, compared to -$52.4 million in Q2 2025 and -$130.6 million in Q1 2025.